Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹1,282 Cr₹1,433 Cr₹1,265 Cr₹1,030 Cr₹579 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,282 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹1,282 Cr
Mar2022₹1,433 Cr
Mar2021₹1,265 Cr
Mar2020₹1,030 Cr
Mar2019₹579 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹1,282 Cr
-10.58
Mar2022 ₹1,433 Cr
13.28
Mar2021 ₹1,265 Cr
22.81
Mar2020 ₹1,030 Cr
78.11
Mar2019 ₹579 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,875.6 Cr 0.1% -11.8% 59.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹350,195.0 Cr -1.1% -2.9% 55.1% Stock Analytics
CIPLA ₹118,275.0 Cr 0.3% 6.1% 56.7% Stock Analytics
DIVIS LABORATORIES ₹117,130.0 Cr 8.2% 11.5% 27.9% Stock Analytics
ZYDUS LIFESCIENCES ₹102,998.0 Cr -3.7% 8.5% 107.7% Stock Analytics
DR REDDYS LABORATORIES ₹98,034.1 Cr 1.8% -4.7% 32.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.1%

-11.8%

59.3%

SENSEX

-2%

-1.1%

19.4%


You may also like the below Video Courses